FORTRESS BIOTECHPRFA (Germany) Top Insiders
CNB0 Stock | EUR 5.85 0.05 0.85% |
Examination of FORTRESS BIOTECHPRFA's management performance can provide insight into the company performance.
FORTRESS |
Symbol | CNB0 |
Name | FORTRESS BIOTECHPRFA 25 |
Type | Stock |
Country | Germany |
Exchange | F |
Information on FORTRESS BIOTECHPRFA 25 Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VALE | Vale SA ADR | |
EGY | Vaalco Energy | |
CMCSA | Comcast Corp | |
BTE | Baytex Energy Corp | |
SOXS | Direxion Daily Semiconductor |
Thematic Opportunities
Explore Investment Opportunities
FORTRESS BIOTECHPRFA Management Team Effectiveness
The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4338) %, meaning that it generated substantial loss on money invested by shareholders. FORTRESS BIOTECHPRFA's management efficiency ratios could be used to measure how well FORTRESS BIOTECHPRFA manages its routine affairs as well as how well it operates its assets and liabilities.FORTRESS BIOTECHPRFA Workforce Comparison
FORTRESS BIOTECHPRFA 25 is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 104,102. FORTRESS BIOTECHPRFA adds roughly 173 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.63. FORTRESS BIOTECHPRFA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. FORTRESS BIOTECHPRFA Price Series Summation is a cross summation of FORTRESS BIOTECHPRFA price series and its benchmark/peer.
About FORTRESS BIOTECHPRFA Management Performance
The success or failure of an entity such as FORTRESS BIOTECHPRFA often depends on how effective the management is. FORTRESS BIOTECHPRFA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of FORTRESS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the FORTRESS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.
Complementary Tools for FORTRESS Stock analysis
When running FORTRESS BIOTECHPRFA's price analysis, check to measure FORTRESS BIOTECHPRFA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FORTRESS BIOTECHPRFA is operating at the current time. Most of FORTRESS BIOTECHPRFA's value examination focuses on studying past and present price action to predict the probability of FORTRESS BIOTECHPRFA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FORTRESS BIOTECHPRFA's price. Additionally, you may evaluate how the addition of FORTRESS BIOTECHPRFA to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |